Clin2
NCT07406334Likely a fitRecruiting

Pneumococcal booster vaccine study for toddlers

Pneumonia, Bacterial

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial tests a new pneumococcal vaccine as a booster shot in toddlers who already got a full primary series. It aims to see if the booster is safe and produces a strong immune response.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
45 people
Ages
1 year to 1.3 years
Study type
Interventional

Who can take part

  • Your child is between 12 and 15 months old
  • Your child completed a 2-dose series of the PCV10 vaccine
  • Your child is generally healthy or has a stable medical condition
  • Your child hasn't had any pneumococcal disease confirmed by a lab

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07406347Not yet recruiting· Phase 1
Testing a new pneumococcal vaccine in healthy babies

This study tests an experimental pneumococcal vaccine in healthy infants. It involves three shots during infancy and a booster around 12-15 months to see if it is safe and how the body responds.

NCT07300267Recruiting· Phase 1
Study of a new pneumococcal vaccine for infants and toddlers

This trial tests a new vaccine called V118C to protect children against pneumococcal disease. It is for two age groups: toddlers aged 12-15 months who already had 3 doses of a standard pneumococcal vaccine, and babies about 2 months old who have not had any pneumococcal vaccine yet.

Madera, California
NCT07660198Recruiting· Phase 3
Pneumonia vaccine catch-up study for kids and teens

This trial tests a catch-up pneumococcal vaccine for children and adolescents who may have missed some doses. It aims to see how safe and effective the vaccine is in healthy kids aged 15 months to 17 years.

Birmingham, Alabama
NCT07348692Recruiting· Phase 3
Pneumonia vaccine study for healthy infants 2 months old

This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.

Fayetteville, Arkansas
NCT06608199Recruiting· Phase 3
Pneumonia vaccine study for healthy infants

This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.

Denpasar, Bali
NCT07300644Recruiting· Phase 2
Pneumococcal vaccine trial for infants and children up to 5 years

This trial tests a new pneumococcal vaccine (PCV24) in healthy infants and children. It aims to protect against serious infections like pneumonia and meningitis caused by pneumococcal bacteria.

Huanggang, Hubei

Hear when a new Pneumonia, Bacterial trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.